Slides
Page 1
Report for quarter 4 and full-year 2025 January22, 2026
Page 2
Ulrika Kolsrud President and CEO
Page 3
3 Highlights Q4 2025 • Organic sales decline mainly due to lower prices • Higher market shares in >65 % of retail branded sales • Strong growth in strategic segments • Higher profit and margins, strong cash flow • New organization from Jan 1, 2026 • SG&A cost savings program initiated • Acquisition of Edgewell’s feminine care business in North America • Sustainability leadership recognized through the EcoVadis Platinum medal and CDP’s A rating EBITA excl. IACOrganic sales growth +4.6% Organic: +3.8% EPSEBITA margin excl. IAC 14.7% +160bps SEK 5,117m +3% -1.1% SEK 4.69m +14%
Page 4
Health & Medical Business highlights • Positive organic sales growth • Volume growth both for Incontinence Products and Medical Solutions • Growth across therapy areas – Wound Care, Compression and Orthopedics • Launch of TENA Proskin Flex with enhanced ComfiStretch belt • Upgraded Cutimed® Siltec® Sorbact®, supported by campaign “Imagine a world where wounds heal faster”
Page 5
5 Consumer Goods Business highlights • Higher market shares in >65 % of branded sales • Strong volume growth for Incontinence Products • Good underlying growth in Feminine Care • Baby Care sales down but growth for Libero • Consumer Tissue sales down but growth in Brands • High launch activity – TENA pads and pants in Latin America upgraded with Proskin formula – New SmartPROTECT technology introduced on Saba® and Nosotras® ultra thin day pads – Saba® super premium pads now even better – Tempo® hankies in sustainable paper packaging
Page 6
Professional Hygiene Business highlights • Organic sales declined due to continued challenging market conditions • Strong growth of premium products • Launch of Tork PeakServe® Automatic Hand Towel Dispenser • Launch of Tork Reflex Dispenser with Natural Wiping Paper • Volume fighters to compete across price tiers
Page 7
Strong development of product superiority 40% 56% 59% 64% 73% 2017 2020 2023 2024 2025
Page 8
Fredrik Rystedt EVP and CFO
Page 9
Report for Quarter 4 and full-year 2025 9 Sales development Net sales Q4 2024 Net sales Q4 2025 Currency SEK 37.8bn -0.2% -0.9% -7.1% SEK 34.7bn Reported growth: -8.2% Organic sales growth: -1.1% + Health & Medical - Consumer Goods - Professional Hygiene - Health & Medical - Consumer Goods - Professional Hygiene Health & Medical • Incontinence Health Care • Medical Solutions Consumer Goods • Incontinence Retail • Feminine Care • Baby Care • Consumer Tissue Professional Hygiene Organic sales growth: +0.7% +0.5% +1.1% -2.0% +6.9% -0.6% -3.5% -4.4% -0.8% Volume Price/mix
Page 10
Report for Quarter 4 and full-year 2025 10 Margin development Q4 2024 Q4 2025Impact Gross Profit Margin A&P SG&A (excl. A&P) 13.1% +180bps -40bps +20bps 14.7% - Lower sales prices + Lower COGS Health & Medical Consumer Goods Professional Hygiene 18.7% 12.9% 19.5% EBITA margin excl. IAC:
Page 11
Report for Quarter 4 and full-year 2025 11 Operating cash flow 5.9 4.3 3.2 6.5 3.3 3.8 1.5 5.3 4.4 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 SEKbn
Page 12
Report for Quarter 4 and full-year 2025 12 Balance sheet 62.9 53.7 30.8 26.5 3.1 2.0 1.2 1.0 0 0,5 1 1,5 2 2,5 3 3,5 4 4,5 5 0 10 20 30 40 50 60 70 2022 2023 2024 2025 Net Debt, SEKbn Net Debt / EBITDA excl. IAC SEKbn
Page 13
13 Full-year 2025 Stability and high profitability in a challenging environment Organic sales growth +4.6% Organic: +3.8% EBITA margin excl. IAC 14.1% +0.9% Net sales SEK 138,494m EBITA excl. IAC SEK 19,572m
Page 14
EPS Growth Earnings per share excl. IAC and amortization of acquisition-related intangible assets 1) Adjusted for US Tax reform 2017 20171) SEK 12.3 per share SEK 19.4 per share 2025 +58% CAGR +6%
Page 15
15 Dividend SEK 8.75 per share +6% 2018 2019 2020 2021 2022 2023 2024 2025 5.75 6.25 6.75 7.00 7.25 7.75 Proposed dividend 20251) 1) Board of Directors proposal 8.25 Dividend, SEK per share 8.751) Report for Quarter 4 and full-year 2025
Page 16
Ulrika Kolsrud President and CEO
Page 17
Summary • Q4 – a strong finish to 2025 – Strong innovation delivery – Growth in strategic segments and higher market shares – High profit and margins – Stable delivery in a challenging market • Initiatives to accelerate profitable volume growth – New organisation – Cost save program – Feminine care acquisition in North America • Strong financial position – 2nd share buy back program – Proposal of increase in dividend
Page 18
Priorities 2026 • Customers and consumers first! • Grow market shares, supported by innovation • Integrate Edgewell acquisition to strengthen Personal Care business in North America • Execute SG&A savings to invest in profitable growth and deliver COGS savings • Increase operational flexibility and efficiency • Unleash the full power of the organization Drive profitable volume growth
Page 19
Essity Capital Markets Day 2026 Save the date Essity’s Capital Markets Day May 7, 2026 at our office in Gothenburg, Sweden Welcome!
Page 20
Every day our brands care for the hygiene and health of a billion people across 150 countries This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual report for a better understanding of these risks and uncertainties.
Page 21
21 Q&A